Ruxolitinib treatment for bronchiolitis obliterans syndrome following hematopoietic stem cell transplant in a patient with primary hemophagocytic lymphohistiocytosis

Chin Med J (Engl). 2021 Jan 5;134(13):1624-1625. doi: 10.1097/CM9.0000000000001324.
No abstract available

Publication types

  • Letter

MeSH terms

  • Bronchiolitis Obliterans* / drug therapy
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Lymphohistiocytosis, Hemophagocytic* / drug therapy
  • Nitriles
  • Pyrazoles / therapeutic use
  • Pyrimidines

Substances

  • Nitriles
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib